Year |
Citation |
Score |
2019 |
Jeong J, Jager A, Domizi P, Pavel-Dinu M, Gojenola L, Iwasaki M, Wei MC, Pan F, Zehnder JL, Porteus MH, Davis KL, Cleary ML. High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells. Blood Advances. 3: 2825-2835. PMID 31582391 DOI: 10.1182/Bloodadvances.2019000450 |
0.317 |
|
2018 |
Duque-Afonso J, Lin CH, Han K, Morgens DW, Jeng EE, Weng Z, Jeong J, Wong SHK, Zhu L, Wei MC, Chae HD, Schrappe M, Cario G, Duyster J, Sakamoto KM, et al. CBP modulates sensitivity to dasatinib in pre-BCR+ acute lymphoblastic leukemia. Cancer Research. PMID 30262461 DOI: 10.1158/0008-5472.Can-18-1703 |
0.586 |
|
2018 |
Lin CH, Wong SH, Kurzer JH, Schneidawind C, Wei MC, Duque-Afonso J, Jeong J, Feng X, Cleary ML. SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression. Cell Reports. 23: 1166-1177. PMID 29694893 DOI: 10.1016/J.Celrep.2018.03.124 |
0.381 |
|
2016 |
Duque-Afonso J, Lin CH, Han K, Wei MC, Feng J, Kurzer J, Schneidawind C, Wong SH, Bassik MC, Cleary ML. E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia. Cancer Research. PMID 27758892 DOI: 10.1158/0008-5472.Can-16-1899 |
0.61 |
|
2015 |
Wong SH, Goode DL, Iwasaki M, Wei MC, Kuo HP, Zhu L, Schneidawind D, Duque-Afonso J, Weng Z, Cleary ML. The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential. Cancer Cell. PMID 26190263 DOI: 10.1016/J.Ccell.2015.06.003 |
0.305 |
|
2015 |
Duque-Afonso J, Wei MC, Lin C, Feng J, Buechele C, Wong SH, Bassik MC, Cleary ML. Oncogenic Role for the Lck/ZAP70/PLCG2 Signaling Pathway in Pre-B-ALL Pathogenesis Blood. 126: 810-810. DOI: 10.1182/Blood.V126.23.810.810 |
0.614 |
|
2014 |
Wei MC, Cleary ML. Novel methods and approaches to acute lymphoblastic leukemia drug discovery. Expert Opinion On Drug Discovery. 9: 1435-46. PMID 25212992 DOI: 10.1517/17460441.2014.956720 |
0.345 |
|
2013 |
Matheny CJ, Wei MC, Bassik MC, Donnelly AJ, Kampmann M, Iwasaki M, Piloto O, Solow-Cordero DE, Bouley DM, Rau R, Brown P, McManus MT, Weissman JS, Cleary ML. Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens. Chemistry & Biology. 20: 1352-63. PMID 24183972 DOI: 10.1016/J.Chembiol.2013.09.014 |
0.566 |
|
2013 |
Wei MC, Matheny CJ, Bassik MC, Donnelly AJ, Kampmann M, Iwasaki M, Piloto O, Solow-Cordero DE, Bouley D, Rau RE, Brown P, McManus MT, Weissman JS, Cleary ML. Next-Generation NAMPT Inhibitors For ALL Identified By Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens Blood. 122: 171-171. DOI: 10.1182/Blood.V122.21.171.171 |
0.614 |
|
2012 |
Clerc P, Carey GB, Mehrabian Z, Wei M, Hwang H, Girnun GD, Chen H, Martin SS, Polster BM. Rapid detection of an ABT-737-sensitive primed for death state in cells using microplate-based respirometry. Plos One. 7: e42487. PMID 22880001 DOI: 10.1371/Journal.Pone.0042487 |
0.342 |
|
2004 |
Wei MC. Bcl-2-related genes in lymphoid neoplasia International Journal of Hematology. 80: 205-209. PMID 15540893 DOI: 10.1532/Ijh97.04110 |
0.367 |
|
2001 |
Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Molecular Cell. 8: 705-11. PMID 11583631 DOI: 10.1016/S1097-2765(01)00320-3 |
0.574 |
|
2001 |
Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science (New York, N.Y.). 292: 727-30. PMID 11326099 DOI: 10.1126/Science.1059108 |
0.585 |
|
2001 |
Mootha VK, Wei MC, Buttle KF, Scorrano L, Panoutsakopoulou V, Mannella CA, Korsmeyer SJ. A reversible component of mitochondrial respiratory dysfunction in apoptosis can be rescued by exogenous cytochrome c. The Embo Journal. 20: 661-71. PMID 11179211 DOI: 10.1093/Emboj/20.4.661 |
0.547 |
|
2000 |
Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death and Differentiation. 7: 1166-73. PMID 11175253 DOI: 10.1038/Sj.Cdd.4400783 |
0.571 |
|
2000 |
Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y, Wei M, Eng VM, Adelman DM, Simon MC, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Molecular Cell. 6: 1389-99. PMID 11163212 DOI: 10.1016/S1097-2765(00)00136-2 |
0.513 |
|
2000 |
Zha J, Weiler S, Oh KJ, Wei MC, Korsmeyer SJ. Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis. Science (New York, N.Y.). 290: 1761-5. PMID 11099414 DOI: 10.1126/Science.290.5497.1761 |
0.569 |
|
2000 |
Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes & Development. 14: 2060-71. PMID 10950869 |
0.535 |
|
2000 |
Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c Genes & Development. 14: 2060-2071. DOI: 10.1101/Gad.14.16.2060 |
0.37 |
|
1999 |
Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. The Journal of Biological Chemistry. 274: 1156-63. PMID 9873064 DOI: 10.1074/Jbc.274.2.1156 |
0.568 |
|
1998 |
Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. The Embo Journal. 17: 3878-85. PMID 9670005 DOI: 10.1093/Emboj/17.14.3878 |
0.584 |
|
Show low-probability matches. |